[144] Telos Corporation SEC Filing

Rhea-AI Filing Summary

Form 144 filing for Telos Corporation (TLS) discloses a proposed sale of 52,595 shares of common stock through Morgan Stanley Smith Barney LLC on 08/22/2025 on the NASDAQ, with an aggregate market value of $347,353.16. The filer reports total shares outstanding of 72,703,011. The securities to be sold were acquired as restricted stock in five grants between 01/31/2022 and 03/08/2023, totaling the shares listed in the acquisition table. No securities were reported sold in the past three months. The filing includes the standard representation that the seller is not aware of undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine insider notice of planned sale of restricted shares; no past 3-month sales reported.

The filing is a standard Rule 144 notice showing an insider or affiliate intends to sell 52,595 restricted shares via Morgan Stanley Smith Barney LLC on 08/22/2025 at an aggregate value of $347,353.16. The shares were granted in multiple restricted stock awards between 01/31/2022 and 03/08/2023. The filer states no undisclosed material adverse information and reports no sales in the prior three months. Given the disclosed size versus 72,703,011 shares outstanding, this appears to be an administrative disclosure rather than a transformational corporate event.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure of planned sale under Rule 144; consistent with vested restricted stock dispositions.

The document provides the required compliance details: broker, planned sale date, number of shares, acquisition dates and nature (restricted stock), and a representation regarding material nonpublic information. It does not state any trading-plan adoption date or indicate prior recent insider dispositions. From a governance perspective, the filing fulfills statutory notice obligations without revealing additional corporate developments.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	52595	347353.16	72703011	08/22/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/31/2022	Restricted Stock	Issuer			5212	01/31/2022	Not Applicable
Common	03/08/2023	Restricted Stock	Issuer			27814	03/08/2023	Not Applicable
Common	07/01/2022	Restricted Stock	Issuer			6523	07/01/2022	Not Applicable
Common	10/01/2022	Restricted Stock	Issuer			6523	10/01/2022	Not Applicable
Common	04/01/2022	Restricted Stock	Issuer			6523	04/01/2022	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the Telos Corporation (TLS) Form 144 propose to sell?

The notice proposes sale of 52,595 shares of Telos common stock.

When and through which broker is the sale scheduled in the TLS Form 144?

The planned sale date is 08/22/2025 through Morgan Stanley Smith Barney LLC on NASDAQ.

What is the aggregate market value reported for the planned TLS sale?

The aggregate market value reported is $347,353.16.

How and when were the shares being sold acquired according to the filing?

All listed shares were acquired as restricted stock in grants dated between 01/31/2022 and 03/08/2023.

Does the filing report any sales by the same person in the past three months?

The filing states Nothing to Report for securities sold during the past three months.